Dottikon Es Holding AG
SIX:DESN
Intrinsic Value
Dottikon ES Holding AG engages in the development and manufacture of chemicals, intermediates, and pharmaceutical ingredients. [ Read More ]
The intrinsic value of one
DESN
stock under the Base Case scenario is
187.68
CHF.
Compared to the current market price of 252 CHF,
Dottikon Es Holding AG
is
Overvalued by 26%.
Dottikon Es Holding AG's market capitalization is 3.5B CHF.
DESN stock price is 252 CHF.
DESN stock (187.68 CHF) is 26% less than its price (252 CHF).
DESN stock (223.43 CHF) is 11% less than its price (252 CHF). Open Relative Valuation
DESN.
DESN has positive three-year average ROE (Return on Equity): 10%. The company is efficient at transforming stockholders' equity into net income.
DESN's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 11%.
DESN's ROIC (Return on Invested Capital) has decreased in the last 3 years from 11% to 11%.
DESN's ROE (Return on Equity) for the past 12 months is positive and is equal to 11%.
DESN's ROE (Return on Equity) has increased in the last 3 years from 10% to 11%.
DESN has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
DESN's Revenue has grown by 19% over the past 12 months.
DESN's Revenue is forecast to grow at a rate of 13% per year over the next 3 years.
DESN has positive Net Income for the last twelve months.
DESN's Revenue has been growing by an exceptional 21% per year for the last 3 years.
DESN has positive Operating Income for the last twelve months.
DESN's short-term assets (491m CHF) exceed its short-term liabilties (192m CHF).
DESN has negative Net Debt. This means that the company has more cash and short-term investments (236m CHF) than debt (100m CHF).
DESN has positive Gross Profit for the last twelve months.
DESN has negative Free Cash Flow for the last twelve months.
DESN's long-term assets (1B CHF) exceed its long-term liabilties (330m CHF).
DESN's D/E (Debt to Equity) is very low and is equal to 0.12.
DESN's Altman Z-Score is very high and is equal to 6.71.
DESN earns more than enough operating income (101m CHF) to safely cover interest payments on its debt (649k CHF).
Valuation Backtest
Dottikon Es Holding AG
Run backtest to discover the historical profit from buying and selling
DESN
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Dottikon Es Holding AG
Balance Sheet Decomposition
Dottikon Es Holding AG
| Current Assets | 490.7m |
| Cash & Short-Term Investments | 236.2m |
| Receivables | 77m |
| Other Current Assets | 177.6m |
| Non-Current Assets | 681.3m |
| Long-Term Investments | 1.9m |
| PP&E | 633.4m |
| Intangibles | 400k |
| Other Non-Current Assets | 45.5m |
| Current Liabilities | 191.8m |
| Accounts Payable | 24m |
| Accrued Liabilities | 107.1m |
| Other Current Liabilities | 60.7m |
| Non-Current Liabilities | 138.6m |
| Long-Term Debt | 100m |
| Other Non-Current Liabilities | 38.6m |
Earnings Waterfall
Dottikon Es Holding AG
|
Revenue
|
338.2m
CHF
|
|
Cost of Revenue
|
-109.7m
CHF
|
|
Gross Profit
|
228.6m
CHF
|
|
Operating Expenses
|
-127.5m
CHF
|
|
Operating Income
|
101m
CHF
|
|
Other Expenses
|
-14.9m
CHF
|
|
Net Income
|
86.2m
CHF
|
Free Cash Flow Analysis
Dottikon Es Holding AG
DESN Profitability Score
Profitability Due Diligence
Dottikon Es Holding AG's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Dottikon Es Holding AG's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
DESN Solvency Score
Solvency Due Diligence
Dottikon Es Holding AG's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Score
Dottikon Es Holding AG's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DESN Price Targets Summary
Dottikon Es Holding AG
Shareholder Return
DESN Price
Dottikon Es Holding AG
| Average Annual Return | 68.59% |
| Standard Deviation of Annual Returns | 89.3% |
| Max Drawdown | -48% |
| Market Capitalization | 3.5B CHF |
| Shares Outstanding | 13 812 060 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Dottikon Es Holding AG
Country
Industry
Market Cap
Dividend Yield
Description
Dottikon ES Holding AG engages in the development and manufacture of chemicals, intermediates, and pharmaceutical ingredients. The company is headquartered in Dottikon, Aargau and currently employs 665 full-time employees. The company went IPO on 2005-03-31. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The firm also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. The company also held a 33.9%-stake in SYSTAG, System Technik AG.
Contact
IPO
Employees
Officers
The intrinsic value of one
DESN
stock under the Base Case scenario is
187.68
CHF.
Compared to the current market price of 252 CHF,
Dottikon Es Holding AG
is
Overvalued by 26%.
You don't have any saved screeners yet
